Helpful Resources & Research The following sources were consulted to verify the information in this article and may be useful to readers seeking more guidance: American Diabetes Association: What Can I Bring on a Plane
Study 1: The SURMOUNT-1 Trial (Obesity) Title: TZ Once Weekly for the Treatment of Obesity Summary: This landmark Phase 3 trial demonstrated that Tirzepatide achieved substantial reductions in body weight (up to 20.9%) in non-diabetic subjects, significantly outperforming placebo
Large-scale observational studies and meta-analyses of cardiovascular outcome trials have not identified an increased risk of breast cancer among patients using these medicines
It is not a drug, food, or cosmetic, and no one should consume it
For many of us, theres likely a way of maximising our results on semaglutide to kickstart our weight loss
Available at: (Accessed December 5, 2017)